Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Auditor change
Consulting agrmnt
Upcoming conference date
Acq. announced
Director departure
Appointed director
Employment agrmnt
Quarterly results
|
|
RespireRx Pharmaceuticals Inc. (CORX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/16/2012 |
8-K
| Entered into consulting agreement|
Docs:
|
"Agreement and Plan of Merger, by and among Cortex Pharmaceuticals, Inc., Pier Acquisition Corp. and Pier Pharmaceuticals, Inc",
"CORTEX PHARMACEUTICALS AND PIER PHARMACEUTICALS CONSUMMATE MERGER Merger Creates New Biotechnology Company Focused on Brain-Controlled Breathing Disorders IRVINE, CA & LOUISVILLE, CO — Cortex Pharmaceuticals, Inc. and Pier Pharmaceuticals, Inc., a privately held biopharmaceutical company, announced they have consummated a merger under which Cortex and Pier have merged in an all-stock transaction, with Pier becoming a wholly-owned subsidiary of Cortex, effective August 10, 2012. This merger brings together a series of unique drug products that in preclinical animal models and early clinical studies have shown efficacy in preventing or reversing drug-induced respiratory depression and in reducing obstructive sleep apnea. Phase 2 clinical assets include Cortex's CX1739, a compound targeting o..." |
|
|
|